High Concentration Anti-Ass Protofibril Antibody Formulations And Methods Of Use Thereof

Patent No. EP4121007 (titled "High Concentration Anti-Ass Protofibril Antibody Formulations And Methods Of Use Thereof") was filed by Eisai R&D Management on Mar 19, 2021. The application was issued on Jul 2, 2025.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
WUESTHOFF & WUESTHOFFApr 1, 2026SONNENHAUSER

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP4121007

EISAI R&D MANAGEMENT
Application Number
EP21722538A
Filing Date
Mar 19, 2021
Status
Granted And Under Opposition
May 29, 2025
Publication Date
Jul 2, 2025